CMTM6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.47209999979259E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.54540000019132E-07 |
Normal-vs-Stage2 |
2.219100E-03 |
Normal-vs-Stage3 |
5.88409999946471E-07 |
Normal-vs-Stage4 |
1.237150E-03 |
Stage1-vs-Stage2 |
1.389600E-01 |
Stage1-vs-Stage3 |
8.437200E-01 |
Stage1-vs-Stage4 |
1.790190E-01 |
Stage2-vs-Stage3 |
1.813230E-01 |
Stage2-vs-Stage4 |
9.162800E-01 |
Stage3-vs-Stage4 |
1.984600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.19689999986828E-07 |
Normal-vs-AfricanAmerican |
1.42830000005034E-06 |
Normal-vs-Asian |
1.633430E-01 |
Caucasian-vs-AfricanAmerican |
4.810000E-01 |
Caucasian-vs-Asian |
6.443000E-01 |
AfricanAmerican-vs-Asian |
3.968800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.831299999977E-06 |
Normal-vs-Female |
2.22830000007335E-07 |
Male-vs-Female |
2.805400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.029200E-04 |
Normal-vs-Age(41-60Yrs) |
1.75390000001219E-06 |
Normal-vs-Age(61-80Yrs) |
1.17809999999885E-06 |
Normal-vs-Age(81-100Yrs) |
8.41189999878367E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.874000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.073800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.163580E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.862800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.067700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.923600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.900800E-03 |
Normal-vs-Grade 2 |
4.29960000047913E-07 |
Normal-vs-Grade 3 |
4.49710000349768E-08 |
Normal-vs-Grade 4 |
7.228000E-04 |
Grade 1-vs-Grade 2 |
9.418600E-01 |
Grade 1-vs-Grade 3 |
3.916000E-01 |
Grade 1-vs-Grade 4 |
8.244400E-01 |
Grade 2-vs-Grade 3 |
7.432400E-02 |
Grade 2-vs-Grade 4 |
6.259400E-01 |
Grade 3-vs-Grade 4 |
1.166570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.17389999837658E-08 |
Normal-vs-ccB subtype |
9.85690000000483E-05 |
ccA subtype-vs-ccB subtype |
2.697400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.54119999990132E-07 |
Normal-vs-N1 |
2.598200E-01 |
N0-vs-N1 |
3.729600E-01 |
|
|